2020
Development and evaluation of patient reported outcomes-based performance measures during chemotherapy.
Urick B, Stover A, Deal A, Jansen J, Chiang A, Cleeland C, Zylla D, Basch E. Development and evaluation of patient reported outcomes-based performance measures during chemotherapy. Journal Of Clinical Oncology 2020, 38: e19175-e19175. DOI: 10.1200/jco.2020.38.15_suppl.e19175.Peer-Reviewed Original ResearchHigh symptom burdenRelative riskSymptom burdenPhysical functioningCut pointsLow self-reported physical functioningSelf-reported physical functioningProportion of patientsEvaluation of patientsLower physical functioningOncology Care ModelShort formCut-point scoreChemotherapy cyclesSymptom controlCancer CenterSymptom SurveyMultiple symptomsCare modelPatientsGreater severityOutcome performance measuresSymptom itemsPRO itemsPrevalence
2019
Development and testing of patient-reported outcome performance measures (PRO-PMs) for oncology practice.
Stover A, Urick B, Deal A, Jansen J, Henson S, Miller R, Smith T, Scholle S, Chiang A, Cleeland C, Deutsch Y, Zylla D, Pitzen C, Snyder C, McNiff K, Krzyzanowska M, Spears P, Smith M, Geoghegan C, Basch E. Development and testing of patient-reported outcome performance measures (PRO-PMs) for oncology practice. Journal Of Clinical Oncology 2019, 37: 173-173. DOI: 10.1200/jco.2019.37.27_suppl.173.Peer-Reviewed Original ResearchOncology practiceSymptom managementOutcome performance measuresCancer typesCommunity oncology practicesRisk-adjustment variablesNational Quality ForumRisk-adjusted ratesActionable symptomsChemotherapy cyclesSymptom burdenInsurance typeInclusion criteriaLinear mixed modelingPractice variationGeneralized linear mixed modelingDay 5SymptomsQuality ForumPatientsRA variablesPractice levelMeaningful thresholdMulti-stakeholder consensusMixed modeling